<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="1703">
  <stage>Registered</stage>
  <submitdate>25/09/2007</submitdate>
  <approvaldate>25/09/2007</approvaldate>
  <nctid>NCT00535171</nctid>
  <trial_identification>
    <studytitle>Venous Thromboembolism Taskforce Audit Program</studytitle>
    <scientifictitle>Venous Thromboembolism Taskforce Audit Program</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>DIREG_L_01927</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Venous Thrombosis</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Diseases of the vasculature and circulation including the lymphatic system</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Blood </conditioncode1>
      <conditioncode2>Clotting disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions />
    <comparator />
    <control />
  </interventions>
  <outcomes />
  <eligibility>
    <inclusivecriteria>-  Hospital admission for an acute illness with an in-patient hospital stay of 3 days or
             more.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Patients who have undergone any type of surgery during current admission

          -  Patients who are admitted to a ward or department that is excluded from this study e.g
             psychiatric, paediatric, maternity, intensive care unit, coronary care unit.

          -  Prior enrollment in this protocol during current admission

          -  Prior enrollment in a VTE study involving pharmaceutical or mechanical treatment
             within last 90 days.

          -  Admission for suspected or diagnosed deep vein thrombosis

        The above information is not intended to contain all considerations relevant to a patient's
        potential participation in a clinical trial.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/06/2007</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>8764</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>Sanofi-Aventis - MacQuarie Park</hospital>
    <postcode> - MacQuarie Park</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Sanofi</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>To determine the effect of an interventional campaign run by a dedicated "VTE Nurse Educator"
      over a 6-month period and the effect on prophylaxis rates.

      To determine the proportion of medically admitted patients with risk factors for VTE.

      To assess and compare the use of venous thromboembolism (VTE) prophylaxis in hospitalized
      medical patients versus recommendations and current guidelines.

      To determine the patient characteristics of those deemed to be at risk of VTE. To determine
      the proportion of patients receiving appropriate thromboprophylaxis for their risk.

      To determine the type and duration (where possible) of prophylaxis used.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00535171</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Fiona Howard</name>
      <address>Sanofi</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>